Clarifying the function of genes at the chromosome 16p13 locus in type 1 diabetes: CLEC16A and DEXI
- PMID: 31570815
- PMCID: PMC7108966
- DOI: 10.1038/s41435-019-0087-7
Clarifying the function of genes at the chromosome 16p13 locus in type 1 diabetes: CLEC16A and DEXI
Abstract
More than a decade after the discovery of a novel type 1 diabetes risk locus on chromosome 16p13, there remains complexity and controversy over the specific gene(s) that regulate diabetes pathogenesis. A new study by Nieves-Bonilla et al. shows that one of these genes, DEXI, is unlikely to contribute to type 1 diabetes pathogenesis and positions the endolysosomal E3 ubiquitin ligase CLEC16A as the primary culprit by which this gene locus influences diabetes risk.
Conflict of interest statement
Figures
Comment on
-
The type 1 diabetes candidate gene Dexi does not affect disease risk in the nonobese diabetic mouse model.Genes Immun. 2020 Jan;21(1):71-77. doi: 10.1038/s41435-019-0083-y. Epub 2019 Aug 22. Genes Immun. 2020. PMID: 31435002 Free PMC article.
References
-
- Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med. 2009;360:1646–54. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
